Global Coronary Stents Market – Industry Trends and Forecast to 2017-2024

Data Bridge Market Research new Insight’s on “Global Coronary Stents Market is projected to reach 6.4 billion by 2024, from USD 5.3 billion in 2016 growing at a CAGR of 2.4% during the forecast period of 2017 to 2024”.

Free Download Sample Report @


  • Global Coronary Stents Market is segmented on the basis of product type, usability, end-user, distribution channel and geography.
  • On the basis of the type, the market is segmented into dual therapy stent, bioresorbable vascular scaffold (BVS), drug-eluting stent (DES), bio-engineered stent, and bare metal stent.
  •  The drug eluting stent market is segmented into biodegradable and non-biodegradable. Also, based on drug, the market is segmented into paclitaxel and limus-based drugs.
  • Based on application, the market is segmented into coronary artery disease and peripheral artery disease.

Major Market Competitors:

Some of the major players operating in this market are Abbott Vascular, SciTech, Boston Scientific Corporation, Minvasys, Medinol Ltd, iVascular SLU, Elixir Medical Corporation, Inspire MD, Stentys SA,Hexacath, Medtronic, Andramed GmbH, Cordis Corporation, Orbusneich, Eurocor GmbH, Comed B.V., Endocor GmbH,  MicroPort Scientific Corporation, Amaranth Medical, Inc., Terumo Corporation, Degania Silicone Ltd.,  Meril Life Sciences Pvt. Ltd., InSitu Technologies Inc., Alvimedica, Biotronik SE & Co. KG,  AMG International GmbH, Arthesys, Lepu Medical, Translumina GmbH, Accura, Svelte Medical, B. Braun Melsungen AG and, Eucatech AG among other companies.

Speak To Analyst @

Market Segmentation:

  • The Global coronary stents market is segmented on the basis of product type, usability, end-user, distribution channel and geography.
  • On the basis of type, the global coronary stents market is segmented into dual therapy stent, bioresorbable vascular scaffold (BVS), drug eluting stent (DES), bio-engineered stent, bare metal stent.
  • Based on geography, the coronary stents market is segmented into geographical regions such as North America, Europe, Asia-Pacific, South America, Middle East and Africa and, Rest of the World.
  • The geographical regions are further segmented into 24 major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and many others.
  • In 2016, North America is expected to dominate the medical coronary stent market followed by Europe and APAC.
  •  However the APAC region is expected to grow at the highest CAGR in the forecast period 2017 to 2024.

Recent Developments:

The usage of coronary stent devices are increasing in today’s market due to the increase in number of heart diseases and other problems related to the cardiovascular system and also owing to its benefits such as reducing mortality, morbidity among the heart attack patients, improving the flow of blood immediately after heart attack, highly recommended for the heart patients having one or two blocked arteries.

The coronary stent devices market will grow in the future because of the unhealthy diet, physical inactivity, unhealthy lifestyle.

The combination of stent with angioplasty is a life saviour when it is performed after a heart attack.

Inquiry Before Buying @

According to British Heart Foundation Cardiovascular Disease Statistics, in 2014 approximately 26% of male and 18% of female premature (under-75s) mortality was attributed to CVD. In total there were almost 42,000 premature deaths from CVD in the UK. According to the WHO, an estimated 17.5 million people died from CVDs in 2012, representing 31% of all global deaths. Of these deaths, an estimated 7.4 million were due to coronary heart disease and 6.7 million were due to stroke.

Over three-quarters of CVD deaths take place in low- and middle-income countries.

Out of the 16 million deaths under the age of 70 due to no communicable diseases, 82% are in low and middle-income countries and 37% are caused by CVDs.

Whereas the main restraint for the coronary stent market is the strict government policies, unconscionable  prices that the patients are paying for the stents which lead them into indebtness and in some cases leaves them without this life-saving treatment, price control on the cardiac stents by the local authority will lead to the halt of introduction of new advanced product in the region, just limited to one or two blocked arteries, for more complex cases of coronary heart disease, bypass surgery is a better choice.

Detailed Report @

About Us-

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact Us-

Data Bridge Market Research

US: +1-888-387-2818


Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.